What question did this study set out to answer?

The aim is to provide an overview of cannabinoid hyperemesis syndrome and its management.

April 4, 2026Revue Médicale Suisse0 citations

Prise en charge du syndrome d’hyperémèse cannabinoïde

JBJonas BallamanCentre universitaire de médecine générale et santé publique, Lausanne CRCaroline ReiffCentre universitaire de médecine générale et santé publique, Lausanne UVUlysse VoirolCotton Research Institute

Key Points

The aim is to provide an overview of cannabinoid hyperemesis syndrome and its management.
Overview of symptoms associated with cannabinoid hyperemesis syndrome.
Discussion of treatment options based on current knowledge.
Illustration of findings with a clinical case.
Approximately one-third of cannabis users are affected by cannabinoid hyperemesis syndrome.
Symptoms include recurrent vomiting, nausea, and abdominal pain.
Temporary relief can be achieved through hot baths or showers.

Abstract

Cannabinoid hyperemesis syndrome (CHS) is a condition that affects approximately one-third of cannabis users. Symptoms include recurrent episodes of vomiting, nausea, and abdominal pain. Affected individuals often find temporary relief by taking hot baths or showers. This article provides an overview of the typical manifestations of CHS and an update on the current knowledge surrounding its cause and treatment, illustrated by a clinical case.

Perguntar à IA

Bookmark

View Full Paper

Cite This Study

Ballaman et al. (Thu,) studied this question.

synapsesocial.com/papers/69d0adc2659487ece0fa4446 https://doi.org/https://doi.org/10.53738/revmed.2026.22.956.47892

Perguntar à IA

Bookmark

View Full Paper